• Oxford Nanopore raises $140 M led by Asian investors biospectrumasia
    March 23, 2018
    This expanded range is designed to address all parts of the existing DNA-sequencing market, as well as enabling new applications that can only be performed with a real-time, scalable, long-read technology.
PharmaSources Customer Service